Mechanisms of anti-atherosclerotic functions of soy-based diets

Journal of Nutritional Biochemistry

Volumn 21, Issue 4, 2010, Pages 255-260

  Nagarajan, Shanmugam ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Atherosclerosis; Cell adhesion; Inflammation; Isoflavones; Soy

Indexed keywords

BETA CONGLYCININ; CASEIN; GENISTEIN; GLYCININ; INTEGRIN; ISOFLAVONE; LACTALBUMIN; OXIDIZED LOW DENSITY LIPOPROTEIN; SOYBEAN PROTEIN; UNCLASSIFIED DRUG;

ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL ACTIVATION; CELL ADHESION; CELL FUNCTION; CHRONIC DISEASE; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DRUG MECHANISM; ENDOTHELIUM CELL; FOAM CELL; HUMAN; INFLAMMATORY DISEASE; LEUKOCYTE MIGRATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; VASCULITIS;

ANIMALS; ATHEROSCLEROSIS; CELL ADHESION; CELL MOVEMENT; DIET; ENDOTHELIAL CELLS; FOAM CELLS; HUMANS; INFLAMMATION; INTEGRINS; ISOFLAVONES; MONOCYTES; PROTECTIVE AGENTS; SOYBEANS; VEGETABLE PROTEINS;

EID: 77649272444     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2009.09.002     Document Type: Review

References (96)

1. D'Armiento F.P., Di Gregorio F., Ciafre S.A., Posca T., Liguori A., Napoli C., et al. Histological findings and evidence of lipid conjugated dienes and malonyldialdehyde in human fetal aortas. Acta Paediatr 82 (1993) 823-828
2. Napoli C., D'Armiento F.P., Mancini F.P., Postiglione A., Witztum J.L., Palumbo G., et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest 100 (1997) 2680-2690
3. Napoli C., Witztum J.L., de Nigris F., Palumbo G., D'Armiento F.P., and Palinski W. Intracranial arteries of human fetuses are more resistant to hypercholesterolemia-induced fatty streak formation than extracranial arteries. Circulation 99 (1999) 2003-2010
4. Napoli C., Glass C.K., Witztum J.L., Deutsch R., D'Armiento F.P., and Palinski W. Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study. Lancet 354 (1999) 1234-1241
5. Reddy K.S. Cardiovascular disease in non-Western countries. N Engl J Med 350 (2004) 2438-2440
6. Lusis A.J., Mar R., and Pajukanta P. Genetics of atherosclerosis. Annu Rev Genomics Hum Genet 5 (2004) 189-218
7. Kolonel L.N. Variability in diet and its relation to risk in ethnic and migration groups. Basic Life Sci 43 (1988) 129-135
8. Adlercreutz H. Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest 50 (1990) 3-23
9. Robertson T.L., Kato H., Rhoads G.G., Kagan A., Marmot M., Syme S.L., et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California. Incidence of myocardial infarction and death from coronary heart disease. Am J Cardiol 39 (1977) 239-243
10. Hori G., Wang M.F., Chan Y.C., Komatsu T., Wong Y., Chen T.H., et al. Soy protein hydrolysate with bound phospholipids reduces serum cholesterol levels inhypercholesterolaemic adult male volunteers. Biosci Biotechnol Biochem 64 (2001) 72-78
11. Tonstad S., Smerud K., and Hoie L.A. comparison of the effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteins, and plasma total homocysteine in hypercholesterolemic subjects. Am J Clin Nutr 76 (2002) 78-84
12. Jenkins D.J., Kendall C.W., Jackson C.J., Connelly P.W., Parker T., Faulkner D., et al. Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr 76 (2002) 365-372
13. McVeigh B.L., Dillingham B.L., Lampe J.W., and Duncan A.M. Effect of soy protein varying in isoflavone content on serum lipids in healthy young men. Am J Clin Nutr 83 (2006) 244-251
14. Reynolds K., Chin A., Lees K.A., Nguyen A., Bujnowski D., and He J.A. Meta-analysis of the effect of soy protein supplementation on serum lipids. Am J Cardiol 98 (2006) 633-640
15. Anthony M.S., Clarkson T.B., Hughes Jr. C.L., Morgan T.M., and Burke G.L. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr 126 (1996) 43-50
16. Anthony M.S., Clarkson T.B., Bullock B.C., and Wagner J.D. Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys. Arterioscler Thromb Vasc Biol 17 (1997) 2524-2531
17. Clarkson T.B. Nonhuman primate models of atherosclerosis. Lab Anim Sci 48 (1998) 569-572
18. Zhang S.H., Reddick R.L., Piedrahita J.A., and Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258 (1992) 468-471
19. Plump A.S., Smith J.D., Hayek T., Aalto-Setala K., Walsh A., Verstuyft J.G., et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71 (1992) 343-353
20. Ni W., Tsuda Y., Sakono M., and Imaizumi K. Dietary soy protein isolate, compared with casein, reduces atherosclerotic lesion area in apolipoprotein E-deficient mice. J Nutr 128 (1998) 1884-1889
21. Adams M.R., Golden D.L., Register T.C., Anthony M.S., Hodgin J.B., Maeda N., et al. The atheroprotective effect of dietary soy isoflavones in apolipoprotein E-/- mice requires the presence of estrogen receptor-alpha. Arterioscler Thromb Vasc Biol 22 (2002) 1859-1864
22. Nagarajan S., Burris R.L., Stewart B.W., Wilkerson J.E., and Badger T.M. Dietary soy protein isolate ameliorates atherosclerotic lesions in apolipoprotein E-deficient mice potentially by inhibiting monocyte chemoattractant protein-1 expression. J Nutr 138 (2008) 332-337
23. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
24. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
25. Vitolins M.Z., Anthony M., and Burke G.L. Soy protein isoflavones, lipids and arterial disease. Curr Opin Lipidol 12 (2001) 433-437
26. Clarkson T. Soy, soy phytoestrogens and cardiovascular disease. J Nutr 132 (2002) 566S-569S
27. Ricketts M.L., Moore D.D., Banz W.J., Mezei O., and Shay N.F. Molecular mechanisms of action of the soy isoflavones includes activation of promiscuous nuclear receptors. A review. J Nutr Biochem 16 (2005) 321-330
28. Xiao C.W., Mei J., and Wood C.M. Effect of soy proteins and isoflavones on lipid metabolism and involved gene expression. Front Biosci 13 (2008) 2660-2673
29. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76 (1994) 301-314
30. Galkina E., and Ley K. Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol 27 (2007) 2292-2301
31. Dong Z.M., Chapman S.M., Brown A.A., Frenette P.S., Hynes R.O., and Wagner D.D. The combined role of P- and E-selectins in atherosclerosis. J Clin Invest 102 (1998) 145-152
32. Ramos C.L., Huo Y., Jung U., Ghosh S., Manka D.R., Sarembock I.J., et al. Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice. Circ Res 84 (1999) 1237-1244
33. Dong Z.M., Brown A.A., and Wagner D.D. Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice. Circulation 101 (2000) 2290-2295
34. Cybulsky M.I., Iiyama K., Li H., Zhu S., Chen M., Iiyama M., et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 107 (2001) 1255-1262
35. Weber C., Negrescu E., Erl W., Pietsch A., Frankenberger M., Ziegler-Heitbrock H.W., et al. Inhibitors of protein tyrosine kinase suppress TNF-stimulated induction of endothelial cell adhesion molecules. J Immunol 155 (1995) 445-451
36. May M.J., Wheeler-Jones C.P., and Pearson J.D. Effects of protein tyrosine kinase inhibitors on cytokine-induced adhesion molecule expression by human umbilical vein endothelial cells. Br J Pharmacol 118 (1996) 1761-1771
37. Majewska E., Paleolog E., Baj Z., Kralisz U., Feldmann M., and Tchorzewski H. Role of tyrosine kinase enzymes in TNF-alpha and IL-1 induced expression of ICAM-1 and VCAM-1 on human umbilical vein endothelial cells. Scand J Immunol 45 (1997) 385-392
38. Caulin-Glaser T., Watson C.A., Pardi R., and Bender J.R. Effects of 17beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression. J Clin Invest 98 (1996) 36-42
39. Setchell K.D. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 68 (1998) 1333S-1346S
40. Lee Y.W., and Lee W.H. Protective effects of genistein on proinflammatory pathways in human brain microvascular endothelial cells. J Nutr Biochem 19 (2008) 819-825
41. Chacko B.K., Chandler R.T., Mundhekar A., Khoo N., Pruitt H.M., Kucik D.F., et al. Revealing anti-inflammatory mechanisms of soy isoflavones by flow: modulation of leukocyte-endothelial cell interactions. Am J Physiol Heart Circ Physiol 289 (2005) H908-915
42. Chacko B.K., Chandler R.T., D'Alessandro T.L., Mundhekar A., Khoo N.K., Botting N., et al. Anti-inflammatory effects of isoflavones are dependent on flow and human endothelial cell PPARgamma. J Nutr 137 (2007) 351-356
43. Kim S., Shin H.J., Kim S.Y., Kim J.H., Lee Y.S., Kim D.H., et al. Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPARalpha. Mol Cell Endocrinol 220 (2004) 51-58
44. Mezei O., Li Y., Mullen E., Ross-Viola J.S., and Shay N.F. Dietary isoflavone supplementation modulates lipid metabolism via PPARalpha-dependent and-independent mechanisms. Physiol Genomics 26 (2006) 8-14
45. Dang Z.C., Audinot V., Papapoulos S.E., Boutin J.A., and Lowik C.W. Peroxisome proliferator-activated receptor gamma (PPARgamma ) as a molecular target for the soy phytoestrogen genistein. J Biol Chem 278 (2003) 962-967
46. Jiang Y., Beller D.I., Frendl G., and Graves D.T. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol 148 (1992) 2423-2428
47. Carr M.W., Alon R., and Springer T.A. The C-C chemokine MCP-1 differentially modulates the avidity of beta 1 and beta 2 integrins on T lymphocytes. Immunity 4 (1996) 179-187
48. Mine S., Tabata T., Wada Y., Fujisaki T., Iida T., Noguchi N., et al. Oxidized low density lipoprotein-induced LFA-1-dependent adhesion and transendothelial migration of monocytes via the protein kinase C pathway. Atherosclerosis 160 (2002) 281-288
49. Boring L., Gosling J., Cleary M., and Charo I.F. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394 (1998) 894-897
50. Gosling J., Slaymaker S., Gu L., Tseng S., Zlot C.H., Young S.G., et al. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest 103 (1999) 773-778
51. Gu L., Laly M., Chang H.C., Prior R.L., Fang N., Ronis M.J., et al. Isoflavone conjugates are underestimated in tissues using enzymatic hydrolysis. J Agric Food Chem 53 (2005) 6858-6863
52. Gu L., House S.E., Prior R.L., Fang N., Ronis M.J., Clarkson T.B., et al. Metabolic phenotype of isoflavones differ among female rats, pigs, monkeys, and women. J Nutr 136 (2006) 1215-1221
53. Nagarajan S., Stewart B.W., and Badger T.M. Soy isoflavones attenuate human monocyte adhesion to endothelial cell-specific CD54 by inhibiting monocyte CD11a. J Nutr 136 (2006) 2384-2390
54. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 110 (2002) 673-687
55. Springer T.A., and Wang J.H. The three-dimensional structure of integrins and their ligands, and conformational regulation of cell adhesion. Adv Protein Chem 68 (2004) 29-63
56. Tozeren A., Mackie L.H., Lawrence M.B., Chan P.Y., Dustin M.L., and Springer T.A. Micromanipulation of adhesion of PMA-stimulated T lymphocytes to planar membranes containing intercellular adhesion molecule-1. Biophys J (1992)
57. Kucik D.F., Dustin M.L., Miller J.M., and Brown E.J. Adhesion-activating phorbol ester increases the mobility of leukocyte integrin LFA-1 in cultured lymphocytes. J Clin Invest 97 (1996) 2139-2144
58. McDowall A., Leitinger B., Stanley P., Bates P.A., Randi A.M., and Hogg N. The I domain of integrin leukocyte function-associated antigen-1 is involved in a conformational change leading to high affinity binding to ligand intercellular adhesion molecule 1 (ICAM-1). J Biol Chem 273 (1998) 27396-27403
59. Woska Jr. J.R., Shih D., Taqueti V.R., Hogg N., Kelly T.A., and Kishimoto T.K. A small-molecule antagonist of LFA-1 blocks a conformational change important for LFA-1 function. J Leukoc Biol 70 (2001) 329-334
60. Wang S.C., Kanner S.B., Ledbetter J.A., Gupta S., Kumar G., and Nel A.E. Evidence for LFA-1/ICAM-1 dependent stimulation of protein tyrosine phosphorylation in human B lymphoid cell lines during homotypic adhesion. J Leukoc Biol 57 (1995) 343-351
61. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139 (1998) 4252-4263
62. Friedrich E.B., Clever Y.P., Wassmann S., Hess C., and Nickenig G. 17Beta-estradiol inhibits monocyte adhesion via down-regulation of Rac1 GTPase. J Mol Cell Cardiol 40 (2006) 87-95
63. Lo S.K., Cheung A., Zheng Q., and Silverstein R.L. Induction of tissue factor on monocytes by adhesion to endothelial cells. J Immunol 154 (1995) 4768-4777
64. Meisel S.R., Xu X.P., Edgington T.S., Dimayuga P., Kaul S., Lee S., et al. Differentiation of adherent human monocytes into macrophages markedly enhances tissue factor protein expression and procoagulant activity. Atherosclerosis 161 (2002) 35-43
65. McGilvray I.D., Lu Z., Bitar R., Dackiw A.P., Davreux C.J., and Rotstein O.D. VLA-4 integrin cross-linking on human monocytic THP-1 cells induces tissue factor expression by a mechanism involving mitogen-activated protein kinase. J Biol Chem 272 (1997) 10287-10294
66. Oeth P., Parry G.C., and Mackman N. Regulation of the tissue factor gene in human monocytic cells. Role of AP-1, NF-kappa B/Rel, and Sp1 proteins in uninduced and lipopolysaccharide-induced expression. Arterioscler Thromb Vasc Biol 17 (1997) 365-374
67. Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol 24 (2004) 1015-1022
68. Steffel J., Luscher T.F., and Tanner F.C. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation 113 (2006) 722-731
69. Hasenstab D., Lea H., Hart C.E., Lok S., and Clowes A.W. Tissue factor overexpression in rat arterial neointima models thrombosis and progression of advanced atherosclerosis. Circulation 101 (2000) 2651-2657
70. Westrick R.J., Bodary P.F., Xu Z., Shen Y.C., Broze G.J., and Eitzman D.T. Deficiency of tissue factor pathway inhibitor promotes atherosclerosis and thrombosis in mice. Circulation 103 (2001) 3044-3046
71. Lin T.H., Rosales C., Mondal K., Bolen J.B., Haskill S., and Juliano R.L. Integrin-mediated tyrosine phosphorylation and cytokine message induction in monocytic cells. A possible signaling role for the Syk tyrosine kinase. J Biol Chem 270 (1995) 16189-16197
72. Dackiw A.P., Nathens A.B., Marshall J.C., and Rotstein O.D. Integrin engagement induces monocyte procoagulant activity and tumor necrosis factor production via induction of tyrosine phosphorylation. J Surg Res 64 (1996) 210-215
73. Weber K.S., Draude G., Erl W., de Martin R., and Weber C. Monocyte arrest and transmigration on inflamed endothelium in shear flow is inhibited by adenovirus-mediated gene transfer of IkappaB-alpha. Blood 93 (1999) 3685-3693
74. Kowala M.C., Recce R., Beyer S., Gu C., and Valentine M. Characterization of atherosclerosis in LDL receptor knockout mice: macrophage accumulation correlates with rapid and sustained expression of aortic MCP-1/JE. Atherosclerosis 149 (2000) 323-330
75. Hall W.L., Vafeiadou K., Hallund J., Bugel S., Reimann M., Koebnick C., et al. Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production. Am J Clin Nutr 83 (2006) 592-600
76. Yla-Herttuala S., Palinski W., Rosenfeld M.E., Parthasarathy S., Carew T.E., Butler S., et al. Evidence for the presence of oxidatively modified LDL in atherosclerotic lesions of rabbits and man. J Clin Invest 84 (1989) 1086-1095
77. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 272 (1997) 20963-20966
78. Kreiger M. The other side of scavenger receptors: pattern recognition for host defense. Curr Opin Lipidol 8 (1997) 275-280
79. Greaves D.R., and Gordon S. Thematic review series: the immune system and atherogenesis. Recent insights into the biology of macrophage scavenger receptors. J Lipid Res 46 (2005) 11-20
80. Khan B.V., Parthasarathy S., Alexander R.W., and Medford R.M. Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest 95 (1995) 1262-1270
81. Takei A., Huang Y., and Lopes-Virella M.F. Expression of adhesion molecules by human endothelial cells exposed to oxidized low density lipoprotein. Influences of degree of oxidation and location of oxidized LDL. Atherosclerosis 154 (2001) 79-86
82. Dwivedi A., Anggard E.E., and Carrier M.J. Oxidized LDL-mediated monocyte adhesion to endothelial cells does not involve NFkappaB. Biochem Biophys Res Commun 284 (2001) 239-244
83. Lee H., Shi W., Tontonoz P., Wang S., Subbanagounder G., Hedrick C.C., et al. Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells. Circ Res 87 (2000) 516-521
84. Miyoshi T., Tian J., Matsumoto A.H., and Shi W. Differential response of vascular smooth muscle cells to oxidized LDL in mouse strains with different atherosclerosis susceptibility. Atherosclerosis (2006)
85. Hamilton J.A., Myers D., Jessup W., Cochrane F., Byrne R., Whitty G., et al. Oxidized LDL can induce macrophage survival, DNA synthesis, and enhanced proliferative response to CSF-1 and GM-CSF. Arterioscler Thromb Vasc Biol 19 (1999) 98-105
86. Sakai M., Biwa T., Matsumura T., Takemura T., Matsuda H., Anami Y., et al. Glucocorticoid inhibits oxidized LDL-induced macrophage growth by suppressing the expression of granulocyte/macrophage colony-stimulating factor. Arterioscler Thromb Vasc Biol 19 (1999) 1726-1733
87. Kapiotis S., Hermann M., Held I., Seelos C., Ehringer H., and Gmeiner B.M. Genistein, the dietary-derived angiogenesis inhibitor, prevents LDL oxidation and protects endothelial cells from damage by atherogenic LDL. Arterioscler Thromb Vasc Biol 17 (1997) 2868-2874
88. Kerry N., and Abbey M. The isoflavone genistein inhibits copper and peroxyl radical mediated low density lipoprotein oxidation in vitro. Atherosclerosis 140 (1998) 341-347
89. Turner R., Baron T., Wolffram S., Minihane A.M., Cassidy A., Rimbach G., et al. Effect of circulating forms of soy isoflavones on the oxidation of low density lipoprotein. Free Radic Res 38 (2004) 209-216
90. Kgomotso T., Chiu F., and Ng K. Genistein- and daidzein 7-O-beta-d-glucuronic acid retain the ability to inhibit copper-mediated lipid oxidation of low density lipoprotein. Mol Nutr Food Res (2008)
91. Damasceno N.R., Goto H., Rodrigues F.M., Dias C.T., Okawabata F.S., Abdalla D.S., et al. Soy protein isolate reduces the oxidizability of LDL and the generation of oxidized LDL autoantibodies in rabbits with diet-induced atherosclerosis. J Nutr 130 (2000) 2641-2647
92. Teixeira Damasceno N.R., Apolinario E., Dias Flauzino F., Fernandes I., and Abdalla D.S. Soy isoflavones reduce electronegative low-density lipoprotein (LDL(-)) and anti-LDL (-) autoantibodies in experimental atherosclerosis. Eur J Nutr 46 (2007) 125-132
93. Wiseman H., O'Reilly J.D., Adlercreutz H., Mallet A.I., Bowey E.A., Rowland I.R., et al. Isoflavone phytoestrogens consumed in soy decrease F(2)-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr 72 (2000) 395-400
94. Vega-Lopez S., Yeum K.J., Lecker J.L., Ausman L.M., Johnson E.J., Devaraj S., et al. Plasma antioxidant capacity in response to diets high in soy or animal protein with or without isoflavones. Am J Clin Nutr 81 (2005) 43-49
95. Choi M.S., Lee W.H., Kwon E.Y., Kang M.A., Lee M.K., Park Y.B., et al. Effects of soy pinitol on the pro-inflammatory cytokines and scavenger receptors in oxidized low-density lipoprotein-treated THP-1 macrophages. J Med Food 10 (2007) 594-601
96. Adams M.R., Golden D.L., Franke A.A., Potter S.M., Smith H.S., and Anthony M.S. Dietary soy beta-conglycinin (7S globulin) inhibits atherosclerosis in mice. J Nutr 134 (2004) 511-516